Advertisement

Table of Contents

April 20, 2017; 129 (16)

INSIDE BLOOD COMMENTARIES

REVIEW ARTICLE

CLINICAL TRIALS AND OBSERVATIONS

  • Targeting Bruton tyrosine kinase with ibrutinib in relapsed/refractory marginal zone lymphoma
    Ariela Noy, Sven de Vos, Catherine Thieblemont, Peter Martin, Christopher R. Flowers, Franck Morschhauser, Graham P. Collins, Shuo Ma, Morton Coleman, Shachar Peles, Stephen Smith, Jacqueline C. Barrientos, Alina Smith, Brian Munneke, Isaiah Dimery, Darrin M. Beaupre and Robert Chen

LYMPHOID NEOPLASIA

MYELOID NEOPLASIA

  • Gain-of-function SAMD9L mutations cause a syndrome of cytopenia, immunodeficiency, MDS, and neurological symptoms
    Bianca Tesi, Josef Davidsson, Matthias Voss, Elisa Rahikkala, Tim D. Holmes, Samuel C. C. Chiang, Jonna Komulainen-Ebrahim, Sorina Gorcenco, Alexandra Rundberg Nilsson, Tim Ripperger, Hannaleena Kokkonen, David Bryder, Thoas Fioretos, Jan-Inge Henter, Merja Möttönen, Riitta Niinimäki, Lars Nilsson, Cornelis Jan Pronk, Andreas Puschmann, Hong Qian, Johanna Uusimaa, Jukka Moilanen, Ulf Tedgård, Jörg Cammenga and Yenan T. Bryceson

THROMBOSIS AND HEMOSTASIS

TRANSPLANTATION

LETTERS TO BLOOD

BLOOD WORK

CONTINUING MEDICAL EDUCATION (CME) QUESTIONS